Patents Examined by Brian T. Gedeon
  • Patent number: 11185684
    Abstract: A system for deploying an electrode array at a target location through a hole formed in the patient's cranium. The system includes an array of electrodes attached to a substrate and an inserter attached to the substrate and/or the array of electrodes. The inserter, substrate and array of electrodes are configured into a first compressed state and are positioned within the lumen of a cannula. Using the cannula, the system is inserted through the hole, the cannula is then removed, and the inserter is used to transition the substrate and electrode array from the first compressed state to a second uncompressed state, thereby deploying the array of electrodes at the target location.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: November 30, 2021
    Inventor: John A. Cadwell
  • Patent number: 11179569
    Abstract: An example of a system and method for protecting a patient diagnosed of cancer from cardiac injury resulting from a chemotherapy treating the cancer. A sequence of cardioprotective pacing sessions may be initiated based on timing of the chemotherapy. Cardiac pacing pulses may be delivered to the patient during each session of the cardioprotective pacing sessions according to a cardioprotective pacing mode for controlling delivery of the cardiac pacing pulses to effect cardioprotection against potential myocardial injury resulting from the chemotherapy. The cardioprotective pacing mode may specifying alternating non-pacing and pacing periods.
    Type: Grant
    Filed: September 19, 2019
    Date of Patent: November 23, 2021
    Assignee: Cardiac Pacemakers, Inc.
    Inventor: Stephen J. Hahn
  • Patent number: 11179046
    Abstract: A method (100) for monitoring an individual's (710) cardiac activity, the method including the steps of: (i) obtaining (110), during a calibration phase, ECG data for the individual from a ECG monitor; (ii) obtaining (120), during the calibration phase, cardiac activity data for the individual from a wearable device including a plethysmographic sensor; (iii) obtaining (130), during a monitoring phase, cardiac activity data for the individual from the wearable device including the plethysmographic sensor; (iii) generating (140) calibration data from the ECG data and cardiac activity data obtained during the calibration phase; and (iv) calibrating (150), using the calibration data, the cardiac activity data obtained by the wearable device during the monitoring phase.
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: November 23, 2021
    Assignee: Koninklijke Philips N.V.
    Inventor: Alberto Giovanni Bonomi
  • Patent number: 11179564
    Abstract: A system for stimulating tissue generally comprises a resorbable implant. The resorbable implant includes a substrate, at least one contact, and a transceiver, wherein the substrate, the at least one contact, and the transceiver are resorbable. The system also includes a controller configured to communicate with the transceiver of the resorbable implant and a power supply connected to the controller. The controller delivers power to the resorbable implant from the power supply. The resorbable implant delivers electrical stimulation to tissue when the resorbable implant receives power.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: November 23, 2021
    Assignees: Washington University, Northwestern University
    Inventors: Wilson Z. Ray, Matthew R. MacEwan, Zohny S. Zohny, John A. Rogers
  • Patent number: 11172862
    Abstract: A defibrillator for guiding a rescuer based on a probability of defibrillation success includes at least one output device and a processor and associated memory, the processor being configured to receive at least two ECG signals over time for a cardiac arrest victim, the at least two ECG signals including at least a first ECG signal at a first point in time and a second ECG signal at a second point in time, process the at least two ECG signals to determine at least two parameters related to the at least two ECG signals, the at least two parameters forming a sequence of parameter sets, analyze a trajectory of the sequence of parameter sets, determine the probability of defibrillation success based on the analysis of the trajectory, and control the at least one output device to provide one or more caregiver prompts based on the probability of defibrillation success.
    Type: Grant
    Filed: May 4, 2020
    Date of Patent: November 16, 2021
    Assignee: ZOLL Medical Corporation
    Inventors: Qing Tan, Gary A Freeman, Frederick J Geheb, James E Brewer
  • Patent number: 11166634
    Abstract: A system for monitoring the state of health of a patient suffering from respiratory disease including a portable medical device, the device including: a) a flow measurement device performing a spirometry measurement, and b) a reflecting photometric sensor performing an oxygen measurement or a measurement of blood oxygen saturation and heart rate. The system includes storage and comparison units in which a personalised plan of action for the patient is stored against which the spirometry and/or oxygen measurement data found are compared, displaying the result of such comparison on the display of a device connected to the internet so as to define the patient's state of health and identify exacerbation of the disease on the basis of data obtained from both such spirometry and oxygen measurements. A method for monitoring the health of a patient suffering from respiratory disease implemented through the system indicated above is also claimed.
    Type: Grant
    Filed: November 16, 2018
    Date of Patent: November 9, 2021
    Assignee: MIR S.R.L.—MEDICAL INTERNATIONAL RESEARCH
    Inventor: Paolo Boschetti Sacco
  • Patent number: 11167145
    Abstract: A system for monitoring and evaluating the ventricular contractility of a heart muscle includes a device for electrically stimulating the heart muscle of a patient, and an extracorporeal blood pressure sensor. A record, responsive to stimulated ventricular contractions, is created by the pressure sensor. The response record is then evaluated to identify a pressure/time, rate-change in arterial pressure (dp/dt) that results within the time duration of a ventricular contraction in a cardiac cycle. In turn, dp/dt is evaluated as an indicator of ventricular contractility and the health of the patient's heart muscle.
    Type: Grant
    Filed: October 30, 2019
    Date of Patent: November 9, 2021
    Assignee: Guy P. Curtis and Frances L. Curtis Trust
    Inventor: Guy P. Curtis
  • Patent number: 11154248
    Abstract: Transducer-based systems and methods may be configured to display a graphical representation of a transducer-based device, the graphical representation including graphical elements corresponding to transducers of the transducer-based device, and also including between graphical elements respectively associated with a set of the transducers and respectively associated with a region of space between the transducers of the transducer-based device. Selection of graphical elements and/or between graphical elements can cause activation of the set of transducers associated with the selected elements. Transducer activation characteristics, such as initiation time, activation duration, activation sequence, and energy delivery characteristics, can vary based on numerous factors. Visual characteristics of graphical elements and between graphical elements can change based on an activation-status of the corresponding transducers.
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: October 26, 2021
    Assignee: KARDIUM INC.
    Inventors: Daniel Martin Reinders, Daniel Robert Weinkam, Roxanne Wai Tak Louie, Danai Bisalputra
  • Patent number: 11154719
    Abstract: A method and device for dynamic device based AV delay adjustment are provided. The method provides electrodes that are configured to be located proximate to an atrial (A) site and a right ventricular (RV) site. The method utilizes one or more processors, in an implantable medical device (IMD), for detecting an atrial paced (Ap) event or atrial sensed (As) event. The method determines a measured AV interval corresponding to an interval between the Ap event or the As event and a ventricular sensed event and calculates a percentage-based (PB) offset based on the measured AV interval. The method automatically dynamically adjusting an AV delay, utilized by the IMD, based on the measured AV interval and the PB offset and manages a pacing therapy, utilized by the IMD, based on the AV delay after the adjusting operation.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: October 26, 2021
    Assignee: Pacesetter, Inc.
    Inventors: Nima Badie, Jan O. Mangual-Soto, Luke C. McSpadden, Aditya Goil, Kyungmoo Ryu
  • Patent number: 11147524
    Abstract: Various embodiments of medical detector systems as well as their methods of operation are disclosed. In one embodiment, one or more detectors are coupled to wearable structures for detecting at least a first tracer within a body portion. In another embodiment, one or more detectors are coupled to a wearable structure, where the detector corresponds to a CMOS chip that directly detects a first radioactive tracer.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: October 19, 2021
    Assignee: Biogen MA Inc.
    Inventors: Ajay Verma, Marisa J. Bober, Victoria Cabot, Courtney D. Hilliard, Ara N. Knaian, Seth O. Newburg, John William Hoppin, Karl F. Schmidt
  • Patent number: 11147616
    Abstract: Outer jacket embodiments for reinforcing liquid core laser ablation catheter embodiments discussed herein may be used to improve the robustness of the laser ablation catheter embodiments. Method embodiments for making reinforced laser ablation catheters having outer jackets are also discussed.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: October 19, 2021
    Assignee: RA MEDICAL SYSTEMS, INC.
    Inventors: Zachary Wood, James B. Laudenslager
  • Patent number: 11141579
    Abstract: A drive device is provided comprising a working pump, the working pump connected to a membrane fluid pump, and the working pump having a working piston able to oscillate axially between two reversal points for contracting and expanding a working chamber, and a control unit for controlling a movement of the working piston between the two reversal points. The controlled movement of the working piston comprises three temporally successive phases, in a first phase the working piston is accelerated to a speed that is greater than a speed at the end of the first phase, in a second phase the working piston is moved such that a specified speed of the working piston, a specified relative pressure in the working chamber, or a specified force of the working piston is substantially kept constant, and in a third phase the working piston is moved at a negative acceleration.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: October 12, 2021
    Assignee: BERLIN HEART GMBH
    Inventor: Robert Steingräber
  • Patent number: 11141597
    Abstract: A leadless biostimulator including an attachment feature to facilitate precise manipulation during delivery or retrieval is described. The attachment feature can be monolithically formed from a rigid material, and includes a base, a button, and a stem interconnecting the base to the button. The stem is a single post having a transverse profile extending around a central axis. The transverse profile can be annular and can surround the central axis. The leadless biostimulator includes a battery assembly having a cell can that includes an end boss. A tether recess in the end boss is axially aligned with a face port in the button to receive tethers of a delivery or retrieval system through an inner lumen of the stem. The attachment feature can be mounted on and welded to the cell can at a thickened transition region around the end boss. Other embodiments are also described and claimed.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: October 12, 2021
    Assignee: Pacesetter, Inc.
    Inventors: Thomas B. Eby, Benjamin F. James, IV, Kavous Sahabi, Travis Lieber, Arees Garabed, Craig E. Mar, Sondra Orts, Tyler J. Strang, Jennifer Heisel, Bernhard Arnar, Daniel Coyle, Daniel Goodman, Scott Smith, Scott Kerns, David Rickheim, Adam Weber, Mike Sacha, Byron Liehwah Chun
  • Patent number: 11135431
    Abstract: An implantable medical device (IMD) includes multiple stimulation engines for independently stimulating respective electrode sets of a lead system while avoiding collisions and/or channel contention during stimulation delivery. A first voltage multiplier is configured to generate an adjustable target voltage having sufficient headroom at an output node that is commonly coupled to anodic nodes of respective stimulation engines. Each stimulation engine includes a secondary voltage multiplier to drive the respective anode and a current regulator powered by a floating voltage supply, wherein the current regulator is coupled to a cathodic node and configured to control how much stimulation current is pulled from the patient tissue.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: October 5, 2021
    Assignee: Advanced Neuromodulation Systems, Inc.
    Inventors: Daran DeShazo, Steven Boor
  • Patent number: 11129573
    Abstract: A catheter assembly or other elongate tubular device for use in establishing vascular or other access within the body of a patient is disclosed. The catheter assembly is equipped with one or more sensors that enable monitoring of one or more physiological aspects of the patient or physical aspect of the catheter assembly itself when the catheter assembly is disposed within the patient. Such aspects include central venous pressure, body temperature, ECG heart signals, oxygen levels, ultrasound data, glucose, etc. The catheter assembly includes the ability to wirelessly transmit or otherwise forward data relating to the detected physiological parameters to another location, such as a patient electronic medical record, smartphone or other mobile device, nurse station, etc. Catheter assemblies configured to detect the frequency of catheter flushing, flushing quality, etc., are also disclosed.
    Type: Grant
    Filed: August 22, 2019
    Date of Patent: September 28, 2021
    Assignee: C. R. Bard, Inc.
    Inventors: Gidon Ofek, Blake Allen, Todd P. McFarland, Samuel A. Francis, Bret Hamatake
  • Patent number: 11129981
    Abstract: Apparatus is provided that includes one or more intra-pulposus exposed electrode surfaces, and a support structure along which the one or more intra-pulposus exposed electrode surfaces are disposed. The support structure is configured to be implanted within a nucleus pulposus of an intervertebral disc of a subject, and to be shaped as a partial ring or a complete ring after implantation. The apparatus further includes one or more extra-pulposus exposed electrode surfaces, which are configured to be implanted outside the nucleus pulposus, in electrical communication with the disc. Control circuitry is provided, which is configured to: configure the intra-pulposus exposed electrode surfaces to be cathodes, and the one or more extra-pulposus exposed electrode surfaces to be one or more anodes, and drive the intra-pulposus exposed electrode surfaces and the one or more extra-pulposus exposed electrode surfaces to electroosmotically drive fluid into the nucleus pulposus. Other embodiments are also described.
    Type: Grant
    Filed: November 26, 2019
    Date of Patent: September 28, 2021
    Assignee: RAINBOW MEDICAL LTD.
    Inventors: Yossi Gross, Gideon Fostick
  • Patent number: 11123556
    Abstract: Some embodiments include a system with a sensor with electrodes including an active electrode and a receiving electrode that is in physical contact with skin of a patient forming an electrical circuit with control electronics of a controller that can measure an electrical parameter using an active electrode and a receiving electrode within a closed loop electrical muscle stimulation system. A sense electrical pulse can be applied to the tissue using the sensor, an electrical parameter measured from the tissue, and a stimulation pulse applied to the tissue based at least in part on the measured electrical parameter. The stimulation is adjustably controlled by the controller to maintain a constant power output to the tissue based on the electrical parameter. A good is coupled to a computer readable medium configured to store usage data, the usage data relating to the patient's use of the good.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: September 21, 2021
    Assignee: CYMEDICA ORTHOPEDICS, INC.
    Inventors: Struan Coleman, Calvin Domenico, Edison Gieswein, Jessica Paparella, Joshua Butters, Marlina Kessler, David Saar, Lee Knox
  • Patent number: 11110267
    Abstract: An electrical treatment apparatus includes an electrode contactable with a body part, a voltage regulator to regulate a voltage applied to the electrode to provide electrical stimulation to the body part, and a control circuit to control the electrical treatment apparatus. While the control circuit is performing the treatment mode in which the voltage regulator is controlled to apply a voltage at a first voltage value corresponding to the treatment mode to the electrode, the control circuit controls the voltage regulator to switch a value of the voltage applied to the electrode from the first voltage value to a second voltage value and to thereafter switch the voltage value from the second voltage value to the first voltage value.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: September 7, 2021
    Assignee: OMRON HEALTHCARE CO., LTD.
    Inventors: Mitsuru Samejima, Yui Watanabe, Makoto Tabata, Shozo Takamatsu, Tetsuya Sato
  • Patent number: 11097100
    Abstract: Disclosed are a needle tip mounted in a cartridge form (in a replaceable manner) to a hand piece of the skin treatment apparatus and allowing a drug to be injected deeply into an invaded potion, and a skin treatment apparatus having the needle tip mounted thereon. The needle tip includes a casing hollow in a vertical direction; a needle unit disposed in the casing and reciprocating in the vertical direction; and at least one sealing member disposed between the casing and the needle unit, wherein the needle unit includes: a housing disposed inside the casing; and at least one needle electrode disposed in the housing of the needle unit and extending in the vertical direction, wherein the at least one sealing member closes a space between the casing and the housing of the needle unit in the vertical direction.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: August 24, 2021
    Assignees: JEISYS MEDICAL INC.
    Inventors: Suk Bae Seo, Ki Chan Kim
  • Patent number: 11096617
    Abstract: The present disclosure provides systems and methods for detecting cardiac activation times of a patient. A system includes a data acquisition system and a processor communicatively coupled thereto. The data acquisition system is configured to detect a plurality of electrograms generated at a plurality of respective electrodes coupled to the patient. The processor is configured to receive the plurality of electrograms from the data acquisition system. The processor is further configured to compute respective energies of the plurality of electrograms. The processor is further configured to detect a cardiac activation time for a first electrogram among the plurality of electrograms based on the respective energy of the first electrogram and the respective energy of a second electrogram that neighbors the first electrogram.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: August 24, 2021
    Assignee: ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC.
    Inventors: Dongfeng Han, Valtino X. Afonso